TMEM39B Activators
TMEM39B Activators constitute a specific category of chemical compounds that have gained recognition within the field of molecular biology and cellular research. These activators are tailored to modulate the activity of the TMEM39B gene, with TMEM39B denoting Transmembrane Protein 39B. This gene encodes a protein found in humans, which belongs to the larger family of transmembrane proteins. While the precise biological functions of TMEM39B are still under investigation, this gene's product is believed to be involved in various cellular processes, potentially contributing to membrane dynamics, signal transduction, or cell-to-cell communication. TMEM39B Activators represent a group of molecules designed to enhance or stimulate the expression and function of the TMEM39B gene, leading to increased activity of the associated protein.
The underlying mechanism by which TMEM39B Activators exert their effects typically involves interactions with specific regulatory elements within the TMEM39B gene, such as its promoter or enhancer sequences. These interactions facilitate the upregulation of gene transcription, culminating in heightened synthesis of the TMEM39B protein. Researchers are actively exploring the precise role of TMEM39B in cellular processes and its downstream effects, aiming to unravel its significance in the context of cell biology and molecular pathways. As scientists continue to investigate the functions and potential implications of TMEM39B activation, the development and optimization of TMEM39B Activators hold promise for advancing our understanding of transmembrane proteins and their involvement in diverse cellular activities.
SEE ALSO...
Items 11 to 20 of 20 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is known to interfere with clathrin-mediated endocytosis. By disrupting this process, it could prevent the internalization and subsequent trafficking of TMEM39B, which is necessary for its proper cellular function. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog inhibits glycolysis, inducing energy stress that might upregulate TMEM39B as part of the cellular response to adapt membrane functions for survival. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3, through its nuclear receptor, can influence the expression of genes related to cell growth and differentiation, potentially affecting TMEM39B in cells requiring membrane modifications. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization. As microtubules are essential for vesicle transport within cells, their disruption can inhibit the intracellular trafficking of TMEM39B, which is necessary for its function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Known for its anti-inflammatory and antioxidant properties, curcumin might influence TMEM39B expression as part of its effect on cellular signaling pathways and stress responses. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin and inhibits microtubule polymerization. Similar to nocodazole, it can impede the trafficking of TMEM39B by disrupting the microtubule network and thus its function. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
Swinholide A severs actin filaments and prevents actin polymerization. Because actin dynamics are crucial for membrane trafficking and cytoskeleton organization, this can inhibit the distribution and function of TMEM39B. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D inhibits actin polymerization. By disrupting the actin cytoskeleton, it can affect the positioning and movement of vesicles and organelles, potentially leading to the inhibition of TMEM39B trafficking and function. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
Oligomycin inhibits mitochondrial ATP synthase, leading to decreased cellular ATP levels. As ATP is vital for many cellular processes including vesicle trafficking and protein function, reduced ATP levels could inhibit the function of TMEM39B. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
By inhibiting HMG-CoA reductase, simvastatin affects cholesterol synthesis, potentially influencing the expression of membrane proteins like TMEM39B to compensate for altered membrane composition. | ||||||